Cheng Allen C, Lowe Michael, Stephens Dianne P, Currie Bart J
Menzies School of Health Research and Northern Territory Clinical School, Flinders University, PO Box 41096, Casuarina NT 0811, Darwin, Australia.
BMJ. 2003 Nov 29;327(7426):1280-2. doi: 10.1136/bmj.327.7426.1280.
When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible
在澳大利亚一家医院对治疗方案进行多次调整后,类鼻疽病的死亡率急剧下降,医生们想确定新药是否起了作用。但事实证明,设计一项符合伦理道德的试验是不可能的。